Barrett Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Barrett Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,500	Closed	-$65K	–	451
2020 Q4	$65K	Hold	1,500	–	–	﹤0.01%	246
2020 Q3	$53K	Hold	1,500	–	–	﹤0.01%	247
2020 Q2	$80K	Hold	1,500	–	–	0.01%	210
2020 Q1	$53K	Hold	1,500	–	–	﹤0.01%	215
2019 Q4	$72K	Hold	1,500	–	–	﹤0.01%	215
2019 Q3	$49K	Hold	1,500	–	–	﹤0.01%	234
2019 Q2	$75K	Hold	1,500	–	–	﹤0.01%	208
2019 Q1	$101K	Sell	1,500 -1,500	-50%	-$87.4K	0.01%	187
2018 Q4	$138K	Hold	3,000	–	–	0.01%	162
2018 Q3	$231K	Hold	3,000	–	–	0.02%	144
2018 Q2	$253K	Buy	+3,000	New	+$262K	0.02%	138

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrett Asset Management's AGIO Position: Q1 2021 in Review

Barrett Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 1,500 shares — an estimated $65K sold.

Barrett Asset Management first reported a position in AGIO in Q2 2018 and held it in 11 quarters. The position peaked at $253K in Q2 2018. 175 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

Barrett Asset Management reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Barrett Asset Management sold 1,500 Agios Pharmaceuticals shares in Q1 2021, an estimated $65K.
Barrett Asset Management first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 11 quarters.
Barrett Asset Management's Agios Pharmaceuticals position peaked at $253K in Q2 2018.
175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Barrett Asset Management's 13F filing for Q1 2021, filed 13 May 2021.